CN103638156A - Traditional Chinese medicine preparation for treating blood stasis angiitis - Google Patents

Traditional Chinese medicine preparation for treating blood stasis angiitis Download PDF

Info

Publication number
CN103638156A
CN103638156A CN201310612584.3A CN201310612584A CN103638156A CN 103638156 A CN103638156 A CN 103638156A CN 201310612584 A CN201310612584 A CN 201310612584A CN 103638156 A CN103638156 A CN 103638156A
Authority
CN
China
Prior art keywords
parts
chinese medicine
blood stasis
medicine preparation
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310612584.3A
Other languages
Chinese (zh)
Other versions
CN103638156B (en
Inventor
宋爱民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Li Chunfeng
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310612584.3A priority Critical patent/CN103638156B/en
Publication of CN103638156A publication Critical patent/CN103638156A/en
Application granted granted Critical
Publication of CN103638156B publication Critical patent/CN103638156B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine preparation for treating blood stasis angiitis. The traditional Chinese medicine preparation comprises the following raw materials in parts by weight: 5 parts of rubus parvifolius, 1 part of grub, 3 parts of paederia foetida, 2 parts of liquorice, 4 parts of phryma leptostachya, 4 parts of elderberry, 4 parts of glechoma longituba, and 3 parts of glabrous sarcandra herb. The traditional Chinese medicine preparation has the effects of promoting blood circulation to remove meridian obstruction, and dispersing blood stasis and relieving pain, and is fast to act, high in treatment effect, safe and convenient, out of toxic and side effects, etc.

Description

The vasculitic Chinese medicine preparation for the treatment of blood stasis type
Technical field
The present invention relates to a kind of vasculitic Chinese medicine preparation of blood stasis type for the treatment of, belong to Chinese medicine technical field.
Background technology
The inaccessible type vasculitis of thrombosis is common peripheral vessels disease, and primary disease is a kind of chronic progressive external Segmental vessel inflammatory occlusive disease, take to involve small artery in extremity and as main, especially take lower limb as common, the clinical male adults of being more common in.Its feature is: the performance of a series of ischemias appears in extremity, and suffering limb is sent out cool, extremity are afraid of cold, feeling of numbness, intermittent claudication, and skin-nourishing changes, and limbs end severe pain when serious, and forms gangrene, and general winter is heavy, summer is lighter, and primary disease belongs to " necrosis " of Chinese medicine.At present, doctor trained in Western medicine is taked operative treatment more.Be divided into clinically: ischemic stage, malnutrition phase, downright bad phase, what the present invention treated is ischemic stage more.The main pathogenesis of primary disease is: qi depression to blood stasis, passages through which vital energy circulates obturation.To take promoting blood circulation to remove obstruction in the collateral, blood-activating analgetic be principle for the treatment of by dialectical clinically, received good result.
Summary of the invention
The object of this invention is to provide a kind of vasculitic Chinese medicine preparation of blood stasis type for the treatment of, there is the features such as determined curative effect, instant effect, curative effect are high, short treating period, safe ready.
The present invention treats the vasculitic Chinese medicine preparation of blood stasis type, and the weight of each raw material of Chinese medicine consists of: Fructus Mume disappear 5 parts, 1 part of grub, 3 parts of Herba Paederiaes, 2 parts, Radix Glycyrrhizae, 4 parts of Herba speranskiae tuberculataes, 4 parts of Ramulus Sambuci Williamsii, 4 parts of Herba Glechomaes, 3 parts of Herba Sarcandraes.
Drug action mechanism in the present invention is as follows:
Fructus Mume disappears: relaxing muscles and tendons to promote blood circulation, eliminating stasis to stop pain, heat-clearing and toxic substances removing.
Grub: removing blood stasis, detumescence, this product has the effect of good removing blood stasis with potent drugs blood.
Herba Paederiae: promoting blood circulation and stopping pain, dampness removing stagnant, the heat-clearing and toxic substances removing that disappears, this product has the effect of good promoting blood circulation by removing wind, pain relieving.
Radix Glycyrrhizae: heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription.
Herba speranskiae tuberculatae: wind-damp dispelling, promoting blood circulation and stopping pain.
Ramulus Sambuci Williamsii: dispelling wind and removing obstruction in the collateral, promoting blood circulation and stopping pain, inducing diuresis to remove edema.
Herba Glechomae: relieving stranguria by diuresis, Qinghua are damp and hot, removing toxic substances and promoting subsidence of swelling.
Herba Sarcandrae: heat-clearing and toxic substances removing, promoting blood circulation to remove blood stasis.
The present invention take that Fructus Mume disappears, grub is principal agent, and Herba Paederiae, Ramulus Sambuci Williamsii are adjuvant, and Radix Glycyrrhizae, Herba speranskiae tuberculatae, Herba Glechomae, Herba Sarcandrae are adjuvant.
Above the effect of all medicines, cure mainly and be all referred to the < < of Shanghai College of Traditional Chinese Medicine Chinese materia medica > >.
Compared with prior art, the present invention has following beneficial effect:
1. Chinese herbal medicine used in the present invention all meets the < < China name pharmacopeia > > of republic regulation, according to compatibility, the present invention has the effect of promoting blood circulation to remove obstruction in the collateral, blood-activating analgetic.
2. the present invention not only has good therapeutical effect to blood stasis type vasculitis.Secondly artery thrombosis, multiple takayasu arteritis are also had to obvious therapeutical effect.
3. the present invention is dialectical accurately, compatibility is reasonable, medication is superior, examine thereby control, treatment must aim at the pathogenesis of disease.
Below for clinical trial is summed up: clinical trial treatment blood stasis type vasculitis patient 200 examples.
The vasculitic symptom of blood stasis type: suffering limb fear of cold, touch send out cool, stolidity, be stationarity pain, intermittent claudication, local skin takes on a red color, dark red or livid purple, lower limb muscles atrophy.
Therapeutic scheme: take embodiment pill, once a bag, day takes three times, 60 days is a course for the treatment of.
Therapeutic outcome: blood stasis type vasculitis patient 100 examples of fully recovering after a course of therapy, account for 50%, 72 examples that take a turn for the better, account for 36%, and invalid 28 examples, account for 14%, total effective rate 86%.Shown in treatment, without any side effects to patient, three large routine tests and hepatic and renal function detect no abnormal.
Treatment standard:
Recovery from illness symptom and sign, skin color recover normal, and subjective symptoms disappears.
Improvement subjective symptoms obviously alleviates, and skin color extremely obviously improves, and substantially recovers former ability to work.
Invalid symptom and sign are not improved.
The specific embodiment
Below in conjunction with embodiment, the present invention is described further.
Embodiment
The weight of raw material of Chinese medicine consists of: Fructus Mume disappear 5 parts, 1 part of grub, 3 parts of Herba Paederiaes, 2 parts, Radix Glycyrrhizae, 4 parts of Herba speranskiae tuberculataes, 4 parts of Ramulus Sambuci Williamsii, 4 parts of Herba Glechomaes, 3 parts of Herba Sarcandraes.
Preparation method: by medicine-feeding concoct qualified, weigh and assort, roll altogether for fine powder and even, cross thin sieve of 80-100 order, with cold boiled water by upper medicated powder general be piller, dry, pack (one bag 10 grams).Oral, once a bag, day takes three times, within 60 days, is a course for the treatment of.
Case 1: patient appoints so-and-so, man, 40 years old, because of right lower extremity end send out cool, be afraid of cold, numb, ache, intermittent claudication, xerosis cutis, color of the leather are gloomy, examine as vasculitis (blood stasis type) in March, 2011 at local hospital, the oral drug therapy moon is remaining invalid, in in May, 2011 Lai Zhenwo institute, give Drug therapy of the present invention after the course for the treatment of symptom all disappear, follow up a case by regular visits to 1 year not recurrence.
Case 2: patient Liu so-and-so, man, 44 years old, because right lower extremity is sent out cool, numbness, pain, local skin be dark red, examine as thromboangiitis, oral Drug therapy of the present invention after the course for the treatment of symptom, sign all disappear, limb activity is freely.Follow up a case by regular visits to not recurrence in a year.
Case 3: patient Zhang, man 47 years old, have hypertension history, prolapse sense in January left lower extremity distending pain, numbness, activity postemphasis, local skin is dark red, be diagnosed as on inspection thromboangiitis, oral Drug therapy of the present invention after the course for the treatment of symptom all disappear, limb activity is freely.Follow up a case by regular visits to not recurrence in a year.

Claims (1)

1. a treatment blood stasis type vasculitic Chinese medicine preparation, is characterized in that the weight of each raw material of Chinese medicine consists of: Fructus Mume disappear 5 parts, 1 part of grub, 3 parts of Herba Paederiaes, 2 parts, Radix Glycyrrhizae, 4 parts of Herba speranskiae tuberculataes, 4 parts of Ramulus Sambuci Williamsii, 4 parts of Herba Glechomaes, 3 parts of Herba Sarcandraes.
CN201310612584.3A 2013-11-26 2013-11-26 The vasculitic Chinese medicine preparation for the treatment of blood stasis type Expired - Fee Related CN103638156B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310612584.3A CN103638156B (en) 2013-11-26 2013-11-26 The vasculitic Chinese medicine preparation for the treatment of blood stasis type

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310612584.3A CN103638156B (en) 2013-11-26 2013-11-26 The vasculitic Chinese medicine preparation for the treatment of blood stasis type

Publications (2)

Publication Number Publication Date
CN103638156A true CN103638156A (en) 2014-03-19
CN103638156B CN103638156B (en) 2015-12-30

Family

ID=50243528

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310612584.3A Expired - Fee Related CN103638156B (en) 2013-11-26 2013-11-26 The vasculitic Chinese medicine preparation for the treatment of blood stasis type

Country Status (1)

Country Link
CN (1) CN103638156B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104027430A (en) * 2014-06-18 2014-09-10 蒋保珍 Traditional Chinese medicine composition for treating blood stasis type uterine myoma
CN104225259A (en) * 2014-10-10 2014-12-24 栾英杰 Traditional Chinese medicine for treating stagnant heat type angiitis and preparation method thereof
CN106138167A (en) * 2016-07-13 2016-11-23 蒋保珍 A kind of Chinese medicine composition treating thrombotic disease

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1557386A (en) * 2004-01-16 2004-12-29 林 刘 Angitis treating medicinal liquor
CN101926976A (en) * 2010-08-24 2010-12-29 郭向荣 Pill for treating angiitis
CN103127483A (en) * 2013-02-25 2013-06-05 杨凤国 External-application medicine used for treating vasculitis, and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1557386A (en) * 2004-01-16 2004-12-29 林 刘 Angitis treating medicinal liquor
CN101926976A (en) * 2010-08-24 2010-12-29 郭向荣 Pill for treating angiitis
CN103127483A (en) * 2013-02-25 2013-06-05 杨凤国 External-application medicine used for treating vasculitis, and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104027430A (en) * 2014-06-18 2014-09-10 蒋保珍 Traditional Chinese medicine composition for treating blood stasis type uterine myoma
CN104225259A (en) * 2014-10-10 2014-12-24 栾英杰 Traditional Chinese medicine for treating stagnant heat type angiitis and preparation method thereof
CN106138167A (en) * 2016-07-13 2016-11-23 蒋保珍 A kind of Chinese medicine composition treating thrombotic disease

Also Published As

Publication number Publication date
CN103638156B (en) 2015-12-30

Similar Documents

Publication Publication Date Title
CN102327449B (en) Traditional Chinese medicine for treating gout
CN103211932B (en) Traditional Chinese medicine composition for treating rheumatism
CN103638156B (en) The vasculitic Chinese medicine preparation for the treatment of blood stasis type
CN101940739A (en) Traditional Chinese medicine for treating gout
CN104857188A (en) Traditional Chinese medicine composite for treating edema
CN102813893B (en) Traditional Chinese medicine for dispelling cold and dampness and stopping pain
CN103110780B (en) External-use traditional Chinese medicine preparation for treating chronic bursitis
CN102441125B (en) Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae
CN102406872B (en) Traditional Chinese preparation for treating rheumatoid arthritis
CN102406801B (en) Traditional Chinese medicine wine preparation for treating ischialgia
CN104352659A (en) Traditional Chinese medicine preparation for treating thrombophlebitis
CN103110880B (en) External traditional Chinese medicine preparation for treating supraspinous muscle tendinitis
CN103705629B (en) A kind of Chinese medicine composition for the treatment of pruritus
CN103638440A (en) Traditional Chinese medicine for treating nonbacterial prostatitis
CN103100034B (en) Externally used traditional Chinese medicine (TCM) preparation for treating costal chondritis
CN104435382A (en) Traditional Chinese medicinal liquor for treating waist and back myofascitis
CN103877500A (en) Medicinal liquor for treating diseases caused by wind-cold-wetness evil
CN103638245B (en) The medicine pill for the treatment of ulcerative colitis
CN104383386A (en) External traditional Chinese medicine tincture for treating shoulder sprain and contusion
CN103638102B (en) The Chinese medicine preparation for the treatment of Senile pruritus
CN104337875A (en) Chinese medicinal pills for treating injury flaccid paralysis
CN117018129A (en) Traditional Chinese medicine composition for treating gout and preparation method thereof
CN103041138A (en) Medicinal composition for treating senile constipation
CN104383075A (en) External traditional Chinese medicine tincture for treating chronic strain type gastrocnemius muscle injury
CN102133343A (en) Traditional Chinese medicine preparation for treating Meniere disease

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Li Chunfeng

Inventor before: Song Aimin

TR01 Transfer of patent right

Effective date of registration: 20170531

Address after: 301700, Tianjin city Wuqing District Wang Qing Tuo Town Shengshi Xin Jiayuan 42-1-1801

Patentee after: Li Chunfeng

Address before: 256100 Yiyuan people's Hospital, Zibo, Shandong, China

Patentee before: Song Aimin

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151230

Termination date: 20171126

CF01 Termination of patent right due to non-payment of annual fee